Skip to main navigation

Investor Relations

Filings & Financials
- Financial Information
  SEC Filings
Stock Info
- Stock Information
  Stock Quote & Chart
- Analyst Coverage
Governance
- Corporate Governance
  Governance Highlights
  
  Board of Directors
  
  Committee Composition
News
- News & Events
  News Releases
  
  Investor Calendar
  
  Presentations
Resources
- Investor Resources
  Investor FAQ
  
  Email Alerts
  
  Contact IR

Investor Relations

News Releases

News Releases

Year

September 15, 2020

10x Genomics Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

September 15, 2020

10x Genomics First to Market With Product to Simultaneously Capture Epigenome and Transcriptome

September 10, 2020

10x Genomics Announces Pricing of Upsized Public Offering

September 8, 2020

10x Genomics Announces Launch of a Follow-On Public Offering

September 1, 2020

10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference

August 11, 2020

10x Genomics Reports Second Quarter 2020 Financial Results

August 6, 2020

10x Genomics to Participate in the UBS Genomics 2.0 and Medtech Innovations Summit

July 14, 2020

10x Genomics Launches Next Generation Immune Profiling Product to Combat COVID-19

July 8, 2020

10x Genomics to Report Second Quarter Financial Results on August 11, 2020

June 17, 2020

10x Genomics Selects First 45 Members for Visium Clinical Translational Research Network

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 22

10x - Toolkits

Print Page
Email Alerts
RSS Feeds
Contact IR

About

Products
Platform
Company
Careers
Support
Community
Contact Us

Legal Notices

Privacy Policy
Terms of Use
Email Preferences
Other Legal Notices

Resources

Publications
Applications
Videos

Headquarters

+1 925 401 7300
+1 800 709 1208
[email protected]

Social

©2019 10x Genomics. All Rights Reserved.